Wikisage, the free encyclopedia of the second generation, is digital heritage
Lennox-Gastaut syndrome: Difference between revisions
Jump to navigation
Jump to search
(2) |
(categ) |
||
| Line 1: | Line 1: | ||
'''Lennox–Gastaut syndrome''' (LGS) is a difficult-to-treat form of childhood-onset [[epilepsy]] that most often appears between the second and sixth year of life. LGS is characterized by a triad of signs including frequent seizures of multiple types, an abnormal EEG pattern of less than 2.5 Hz slow spike wave activity,<ref>[https://en.wikipedia.org/w/index.php?title=Lennox%E2%80%93Gastaut_syndrome&oldid=699385431 wikipedia]</ref> | '''Lennox–Gastaut syndrome''' (LGS) is a difficult-to-treat form of childhood-onset [[epilepsy]] that most often appears between the second and sixth year of life. LGS is characterized by a triad of signs including frequent seizures of multiple types, an abnormal EEG pattern of less than 2.5 Hz slow spike wave activity,<ref>[https://en.wikipedia.org/w/index.php?title=Lennox%E2%80%93Gastaut_syndrome&oldid=699385431 wikipedia]</ref> | ||
== | |||
LGS children with a history of perinatal hypoxia or other perinatal event have earlier age of onset of seizures<ref>[http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489077/ Relationship of Lennox-Gastaut syndrome with perinatal event: A cross-sectional study]</ref> | |||
==Links== | |||
[http://www.neurologyindia.com/article.asp?issn=0028-3886;year=2015;volume=63;issue=4;spage=571;epage=582;aulast=Chandra Endoscopic epilepsy surgery: Emergence of a new procedure] | [http://www.neurologyindia.com/article.asp?issn=0028-3886;year=2015;volume=63;issue=4;spage=571;epage=582;aulast=Chandra Endoscopic epilepsy surgery: Emergence of a new procedure] | ||
==[[Rufinamide]]== | ==[[Rufinamide]]== | ||
[http://www.ejpn-journal.com/article/S1090-3798(16)00004-0/abstract Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study] | [http://www.ejpn-journal.com/article/S1090-3798(16)00004-0/abstract Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study] | ||
| Line 9: | Line 14: | ||
{{Wikidata|Q1544884}} | {{Wikidata|Q1544884}} | ||
<references/> | <references/> | ||
[[Category:disease]] | |||
Revision as of 21:41, 31 January 2016
Lennox–Gastaut syndrome (LGS) is a difficult-to-treat form of childhood-onset epilepsy that most often appears between the second and sixth year of life. LGS is characterized by a triad of signs including frequent seizures of multiple types, an abnormal EEG pattern of less than 2.5 Hz slow spike wave activity,[1]
LGS children with a history of perinatal hypoxia or other perinatal event have earlier age of onset of seizures[2]
Links
Endoscopic epilepsy surgery: Emergence of a new procedure
Rufinamide
Disease classification WHO
G40.7 Lennox-Gastaut syndrome
